Sign in

NCT06811493Completed

Comparison of the Efficacy of One Level and Tow Level of Bilateral Thoracic Erector Spinae Plane Block Combined With General Anesthesia in Laparoscopic Bariatric Surgery for Obese Patients: Randomized Controlled Trial

Comparison of the Efficacy of One Level and Two Level of Bilateral Thoracic Erector Spinae Plane Block Combined With General Anesthesia in Laparoscopic Bariatric Surgery for Obese Patients: Randomized Controlled Trial.

Source: ClinicalTrials.gov · Last updated 22 Apr 2026

Brief summary (registry, in English)

comparison of the feasibility and efficacy of the one-level and two-level thoracic ESP block and their effect on intraoperative and postoperative analgesia in bariatric surgeries.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
31 Jan 2025
Start date
1 Jun 2024
Primary completion date
31 Dec 2025
Lead sponsor
Kasr El Aini Hospital
Diseases
Obesity
NCT number
NCT06811493

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 1 Jun 2024 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • • Refusal of regional block
    • Patients with neurological, psychological disorders or those lacking cooperation
    • Patients scheduled for concomitant laparoscopic cholecystectomy or paraumbilical hernia repair or those with history of previous bariatric surgery or obstructive sleep apnea
    • Patients with anatomic abnormalities at site of injection, skin lesions or wounds at site of proposed needle insertion.
    • Patients with bleeding disorders defined as (INR \>1.4) and/ or (platelet count \<100,000/µL)
    • Patients with hepatic disease e.g. liver cell failure or hepatic malignancy or hepatic enlargement.
    • Patients who are allergic to amide local anesthetics.

Who the study is looking for

  • • Patient age ranges 18 to 60 years old
    • Obese patients ; Body mass index(BMI) ≥ 35 - 50 kg/m2
    • American Society of Anesthesiologists (ASA) physical status classes II to III
    • Patients scheduled for laparoscopic bariatric surgery i.e. sleeve gastrectomy and/or Roux-en-Y gastric bypass (RYGB) surgeries

Age in the registry: 18 years to 60 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Cairo University
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.